Swami U, Graf RP, Nussenzveig RH, Fisher V, et al. SPOP mutations as a Predictive Biomarker for Androgen Receptor-Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clin Cancer Res 2022 Sep 11. pii: 709162. doi: 10.1158/1078-0432.CCR-22-2228.
PMID: 36088616